NTLA

SEC source: 0001193125-25-230424 · ownership.xml · nonDerivative · entry 1

Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,184

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0001193125-25-230420 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,266

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-110979 · ownership.xml · nonDerivative · entry 1

CHASE WILLIAM J · CIK 0001563572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,693

F1 · kind: Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on August 20, 2025 at each separate price.

SEC source: 0000950170-25-098774 · ownership.xml · nonDerivative · entry 1

Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,062

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-093844 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,137

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-093302 · ownership.xml · nonDerivative · entry 2

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,359

F1 · kind: The reported sale of 3,094 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 31, 2025.

SEC source: 0000950170-25-093852 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,369

F1 · kind: Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025.

SEC source: 0000950170-25-093302 · ownership.xml · nonDerivative · entry 1

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,906

F1 · kind: The reported sale of 3,094 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 31, 2025.

SEC source: 0000950170-25-086277 · ownership.xml · derivative · entry 2

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086277 · ownership.xml · nonDerivative · entry 1

GOODMAN JESSE · CIK 0001756929 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,453

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-086287 · ownership.xml · derivative · entry 2

Verwiel Frank · CIK 0001545794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086287 · ownership.xml · nonDerivative · entry 1

Verwiel Frank · CIK 0001545794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,948

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-086271 · ownership.xml · derivative · entry 2

Goff Brian · CIK 0001546216 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086271 · ownership.xml · nonDerivative · entry 1

Goff Brian · CIK 0001546216 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,409

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-086243 · ownership.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086243 · ownership.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,203

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-086231 · ownership.xml · derivative · entry 2

CHASE WILLIAM J · CIK 0001563572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086231 · ownership.xml · nonDerivative · entry 1

CHASE WILLIAM J · CIK 0001563572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,693

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-086223 · ownership.xml · derivative · entry 2

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-086223 · ownership.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,453

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-087887 · ownership.xml · derivative · entry 2

Keresty Georgia · CIK 0001773532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450

Underlying: Common Stock · 11,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

SEC source: 0000950170-25-087887 · ownership.xml · nonDerivative · entry 1

Keresty Georgia · CIK 0001773532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,883

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-061881 · ownership.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,203

F1 · kind: The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

SEC source: 0000950170-25-032263 · ownership.xml · nonDerivative · entry 2

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,369

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-032086 · ownership.xml · nonDerivative · entry 2

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,925

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-032101 · ownership.xml · derivative · entry 2

Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,714

Underlying: Common Stock · 53,714 shares

Expires 2035-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032101 · ownership.xml · nonDerivative · entry 1

Schultes Birgit C · CIK 0002051419 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,215

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032141 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,640

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032125 · ownership.xml · derivative · entry 2

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,714

Underlying: Common Stock · 61,714 shares

Expires 2035-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032125 · ownership.xml · nonDerivative · entry 1

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,866

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032263 · ownership.xml · derivative · entry 3

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,714

Underlying: Common Stock · 45,714 shares

Expires 2035-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032263 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,048

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032248 · ownership.xml · derivative · entry 3

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,000

Underlying: Common Stock · 196,000 shares

Expires 2035-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032248 · ownership.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,077,115

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032192 · ownership.xml · derivative · entry 2

Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,429

Underlying: Common Stock · 67,429 shares

Expires 2035-02-28

F2 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032192 · ownership.xml · nonDerivative · entry 1

Dulac Edward J III · CIK 0001821530 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,524

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

SEC source: 0000950170-25-032086 · ownership.xml · derivative · entry 3

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,143

Underlying: Common Stock · 57,143 shares

Expires 2035-02-28

F3 · derivative.exercise_date: This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

SEC source: 0000950170-25-032086 · ownership.xml · nonDerivative · entry 1

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,497

F1 · security: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit

SEC source: 0000950170-25-011757 · ownership.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,468

F1 · kind: The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

SEC source: 0000950170-25-002115 · ownership.xml · nonDerivative · entry 2

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,048

F2 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003032 · ownership.xml · nonDerivative · entry 1

Dube Michael P · CIK 0002019493 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,640

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003015 · ownership.xml · nonDerivative · entry 1

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,666

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003002 · ownership.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,388

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003028 · ownership.xml · nonDerivative · entry 1

BASTA JAMES · CIK 0001792726 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,497

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003014 · ownership.xml · nonDerivative · entry 1

Hicks Derek · CIK 0001901282 · EVP, Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,878

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-003012 · ownership.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 941,115

F1 · kind: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.

SEC source: 0000950170-25-002115 · ownership.xml · nonDerivative · entry 1

Clark Eliana · CIK 0001914448 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,470

F1 · kind: Sale of 556 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2024.

SEC source: 0000950170-25-001237 · ownership.xml · derivative · entry 2

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,189 shares

Expires 2031-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.

SEC source: 0000950170-25-001237 · ownership.xml · nonDerivative · entry 1

Lebwohl David · CIK 0001810882 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2 · balance_after: Includes 405 and 556 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024, respectively.

SEC source: 0000950170-25-001232 · ownership.xml · derivative · entry 2

Sepp-Lorenzino Laura · CIK 0001777421 · EVP, Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,500 shares

Expires 2031-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 3, 2021, the reporting person was granted 14,000 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.